Vara, the AI-enabled breast cancer detection platform, has raised $8.9 million (€8M) in funding from Smart Family Office (Austria), FJH (Germany), and IBB Ventures. The investment comes as the company expands its successful European operations into emerging markets, with a particular focus on India. The Berlin-based company has established a significant presence in Germany’s National Breast Cancer Screening Program, where its AI…
Paxman has announced the publication of the largest real-world study on scalp cooling to date. The study, known as the Dutch Scalp Cooling Registry, spans 13 years and includes data from 7,424 patients across 68 hospitals in the Netherlands. The findings, published in The Oncologist, provide crucial insights into mitigating chemotherapy-induced alopecia (CIA) and solidifying the understanding of factors that contribute to…
Oncology diagnostics company PreciseDx has successfully raised $20.7 million in Series B funding. This latest investment, led by Eventide Asset Management, brings the company’s total funding to $31.5 million. Other participants in the round include Labcorp, Quest Diagnostics, and GenHenn Capital Venture. The capital infusion is set to accelerate the commercialization of PreciseDx’s flagship product, PreciseBreast, an AI-powered risk assessment tool for…
Lunit, a provider of AI-powered cancer diagnostics and therapeutics, has acquired Volpara Health Technologies, a global leader in breast cancer screening software. Last year when the acquisition was first announced Lunit shared plans to acquire all Volpara shares at AUD 1.15 per share, amounting to a deal worth approximately AUD 292 million (USD 193 million). The acquisition merges Volpara’s advanced breast health…
Lunit, a South Korean company that recently secured $150M, has announced its plan to acquire Volpara Health Technologies, an AI-enabled software company specializing in the early detection and prevention of cancer. The acquisition, which is expected to be completed by the second quarter of 2024, involves Lunit acquiring all Volpara shares at AUD 1.15 per share, amounting to a deal worth approximately…
Maia Oncology, a health tech startup, has raised $4.25M in seed funding to develop a virtual primary care clinic for cancer patients, with an initial focus on breast cancer. The round was co-led and co-incubated by Takeda Digital Ventures and Yosemite with participation from BrightEdge – American Cancer Society, BBG Ventures and Coalition Operators. The company, founded by cancer survivor Liya Shuster-Bier,…
JAMA Oncology has just published data from the Zai Lab‘s Phase 3 PRIME study, highlighting the positive outcomes of ZEJULA (niraparib) as a first-line maintenance therapy for Chinese patients with advanced ovarian cancer. The study reveals that ZEJULA significantly prolongs progression-free survival and reduces the risk of disease progression or death by 55%. These findings offer hope for improved outcomes in a…
iSono Health has announced U.S. Food and Drug Administration (FDA) clearance of the company’s ATUSA System for breast imaging, a first-of-its-kind compact automated whole breast ultrasound system featuring a unique wearable accessory and an intuitive software for automated image acquisition and analysis. Designed to offer enhanced efficiency, consistent accuracy and a comfortable patient experience, ATUSA’s patented technology makes 3D breast ultrasound imaging…
